| # | Drug | Count |
|---|---|---|
| 0 | ADAPALENE | 15169 |
| 1 | AVOBENZONE, OCTISALATE, AND OCTOCRYLENE | 12468 |
| 2 | INSULIN GLARGINE | 6051 |
| 3 | SALICYLIC ACID | 4610 |
| 4 | PREDNISONE | 4219 |
| 5 | INFLIXIMAB | 4066 |
| 6 | ACETAMINOPHEN | 3779 |
| 7 | SECUKINUMAB | 3560 |
| 8 | INFLIXIMAB-DYYB | 3243 |
| 9 | METHOTREXATE SODIUM | 3108 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 3243 | 0.2394 |
| 1 | BENZOYL PEROXIDE | 598 | 0.1032 |
| 2 | AZATHIOPRINE SODIUM | 108 | 0.0994 |
| 3 | COAL TAR | 52 | 0.0963 |
| 4 | AVOBENZONE, OCTISALATE, AND OCTOCRYLENE | 12468 | 0.0960 |
| 5 | ROPEGINTERFERON ALFA-2B | 23 | 0.0943 |
| 6 | SALICYLIC ACID | 4610 | 0.0927 |
| 7 | ADAPALENE | 15169 | 0.0912 |
| 8 | AVATROMBOPAG MALEATE | 70 | 0.0797 |
| 9 | RITUXIMAB-PVVR | 74 | 0.0791 |
| # | Drug class | Count |
|---|---|---|
| 0 | Retinoid [EPC] | 15438 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 8971 |
| 2 | Corticosteroid [EPC] | 6754 |
| 3 | Insulin Analog [EPC] | 6684 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 3935 |
| 5 | Interleukin-17A Antagonist [EPC] | 3820 |
| 6 | GLP-1 Receptor Agonist [EPC] | 3595 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 2843 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 2568 |
| 9 | Interleukin-23 Antagonist [EPC] | 2359 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 23 | 0.0943 |
| 1 | Retinoid [EPC] | 15438 | 0.0703 |
| 2 | Human Immunoglobulin G [EPC] | 393 | 0.0658 |
| 3 | Interleukin-17 Receptor A Antagonist [EPC] | 63 | 0.0640 |
| 4 | Parathyroid Hormone [EPC] | 191 | 0.0445 |
| 5 | Chemokine Receptor Type 4 Interaction [EPC] | 30 | 0.0369 |
| 6 | Methylating Agent [EPC] | 27 | 0.0366 |
| 7 | GLP-2 Analog [EPC] | 270 | 0.0328 |
| 8 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0323 |
| 9 | Opioid Antagonist [EPC] | 19 | 0.0302 |